<DOC>
	<DOCNO>NCT00911560</DOCNO>
	<brief_summary>The purpose study test safety effect , good and/or bad , treatment vaccine neuroblastoma patient cancer . In first part study find high dose vaccine many side effect . We try find effect vaccine give dose patient . The main treatment protocol vaccine . It call `` bivalent vaccine '' mean 2 antigen . An antigen specific protein surface cell . The antigen call GD2L GD3L . We want vaccine cause patient 's immune system make antibody antigen . Antibodies make body attack cancer ( fight infection ) . If patient make antibody 2 antigen vaccine , antibody might also attach neuroblastoma cell lot antigen neuroblastoma ( little part body ) . Then , attached antibody would attract patient 's white blood cell kill neuroblastoma . This protocol also use β-glucan kind sugar yeast . β-glucan take mouth help white blood cell kill cancer . The best way get body make antibody 3 antigen link antigen protein call KLH ( stand : keyhole limpet hemocyanin ) mix substance call QS-21 . But hard get enough QS-21 use identical substance call OPT-821 , get easily large amount use patient .</brief_summary>
	<brief_title>Bivalent Vaccine With Escalating Doses Immunological Adjuvant OPT-821 , Combination With Oral β-glucan High-Risk Neuroblastoma</brief_title>
	<detailed_description />
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Adjuvants , Immunologic</mesh_term>
	<criteria>Diagnosis neuroblastoma ( NB ) define international criterion , [ 104 ] i.e. , histopathology ( confirm MSKCC Department Pathology ) bone marrow metastases plus high urine catecholamine level . Highrisk NB define riskrelated treatment guideline International NB Staging System , [ 104 ] i.e. , stage 4 ( age ) without ( &gt; 18 month old ) MYCN amplification , MYCNamplified stage 3 ( unresectable ; age ) , MYCNamplified stage 4S , disease resistant standard chemotherapy . Highrisk NB ( define ) 1 ) first CR/VGPR 6 month initiation immunotherapy use 3F8 antiGD2 mAbs , 2 ) second subsequent remission . Remission define complete ( CR ) good partial ( VGPR ) remission , accord International Neuroblastoma Response Criteria . [ 104 ] Urine catecholamine level longer take consideration stag . Patients consider VGPR 1 2 MIBG ( + ) sit previously irradiate . Absolute lymphocyte count &gt; = 500/mcl absolute neutrophil count &gt; = 500/mcl . Creatinine ≤ 2.0 mg/dL ALT , AST Alkaline Phosphatase ≤ 2.5 time upper limit normal Bilirubin ≤ 2.0 mg/dL Patients le grade 3 toxicity ( use CTCAE v3.0 ) relate cardiac , neurological , pulmonary gastrointestinal function determine physical exam . Prior treatment immunotherapy , include antibody , allow &gt; = 3 week completion systemic therapy 1st vaccination . Signed informed consent indicate awareness investigational nature program . History allergy KLH , QS21 , OPT821 , glucan . Active lifethreatening infection . Inability comply protocol requirement .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>BETA-D-GLUCAN</keyword>
	<keyword>OPT-821</keyword>
	<keyword>GD2-KLH</keyword>
	<keyword>GD3-KLH</keyword>
	<keyword>QS 21</keyword>
	<keyword>Vaccine</keyword>
	<keyword>05-075</keyword>
</DOC>